The Institute for Glial Sciences (IGS) is pleased to announce the 2nd Annual Translational Glial Sciences (TGS) Conference, taking place October 7, 2026, in the Tinkham Veale University Center at Case Western Reserve University. The TGS Conference will showcase scientists at the forefront of glial sciences and their latest findings about the impact of glia on a variety of diseases, as well as emerging opportunities to target glia for therapeutic impact.
The Conference is hosted annually by IGS, whose mission is to illuminate the hidden role of glia in disease and unlock the era of glial medicines.
Registration is free but capacity is limited.
We are pleased to share that our keynote address will be delivered by Sally Temple, PhD, Co-Founder and Scientific Director of the Neural Stem Cell Institute, and a pioneer in developmental neuroscience and stem cell therapies.
Keynote Speaker: Sally Temple, PhD
Neural Stem Cell Institute
Chair: Paul J. Tesar, PhD
|
Chair: Raeka Aiyar, PhD |
Confirmed Speaker List:
• Keynote Speaker: Sally Temple, PhD – Neural Stem Cell Institute
• Valentina Fossati, PhD – The Jackson Laboratory
• Julie Gerberding, MD, MPH – Foundation for the National Institutes of Health
• Stefan Irion, MD – GC Therapeutics
• Justin Lathia, PhD – Cleveland Clinic
• Brittany Needham, PhD – Indiana University School of Medicine
• Richard Ransohoff, MD – Third Rock Ventures
• Paul Tesar, PhD – Institute for Glial Sciences
• Amy T. Waldman, M.D., M.S.C.E. — Children’s Hospital of Philadelphia
Abstract Submission Is Now Closed
Thank you to everyone who submitted an abstract for TGS 2026. Conference registration is still open, but space is limited.
See Highlights from Our Inaugural TGS Conference
Discover keynote speakers, scientific highlights, and photos from the inaugural 2025 Translational Glial Sciences Conference.